Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
This guide summarizes major world market indices, lists them clearly, and explains what each index measures and how investors use them.
28,656 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Deadly protests in Pakistan’s Karachi and Gilgit-Baltistan have left at least 22 dead and more than 120 injured as cr...
Upstart stock has taken a hard one-way trip downward, leaving some investors wondering if a rebound is possible. This...
As Nvidia gears up for a pivotal fiscal 2027 Q1 print, investors are weighing AI demand, data center momentum, and ma...
Elite investors are reorganizing their portfolios, and big names like bill ackman these super are making strategic be...
A notable institutional purchase in Plains GP Holdings hints at a larger, value-driven view of the energy midstream s...
Lemonade has chased rapid growth, but the real investment signal is in its loss ratio. This article explains why lemo...
Greg Abel could be quietly changing Berkshire Hathaway’s approach. This deep dive explains what his moves might look ...
The memory market has been on a wild ride. After sharp gains earlier this year, Micron and SanDisk pulled back, promp...
Bitcoin is sliding off its all-time highs in what many call this bitcoin's shallowest bear. Learn what that means, wh...
ETFs offer easy diversification and low costs, but missteps can erode returns over time. Learn the top ETF mistakes a...
Insider trades can reveal more than cash changing hands. Explore how a recent Warby Parker director sold shares, what...